AVASTIN

Concentrate for solution for infusion, 25mg/ml
RxActive license

Active substance (INN)

bevacizumab

Pharmaceutical form

Pharmaceutical formConcentrate for solution for infusion
Strength25mg/ml
PackagingUkupno 1 bočica staklena sa 4ml koncentrata za rastvor za infuziju u kartonskoj kutiji
ManufacturerF. Hoffmann-La Roche AG, Switzerland
Therapeutic groupAntineoplastic and immunomodulating agents (L01FG01)
Marketing authorization holder"Hoffmann-La Roche LTD" D.S.D. Podgorica
Authorization dateFebruary 15, 2024

Analogs in Montenegro

7

Other medicines with the same active substance

ALYMSYSRx
Concentrate for solution for infusion, 25mg/mlGH Genhelix S.A.
ALYMSYSRx
Concentrate for solution for infusion, 400mg/16mlGH Genhelix S.A.
AVASTINRx
Concentrate for solution for infusion, 25mg/mlF. Hoffmann-La Roche AG
OYAVASRx
Concentrate for solution for infusion, 25mg/mlGH Genhelix S.A.
OYAVASRx
Concentrate for solution for infusion, 25mg/mlGH Genhelix S.A.
ZirabevRx
Concentrate for solution for infusion, 25mg/mlPfizer Service Company BV
ZirabevRx
Concentrate for solution for infusion, 25mg/mlPfizer Service Company BV
Source: CInMED register